Sight Sciences, Inc.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Indicates a management contract or compensatory plan or arrangement.
- Portions of this exhibit are redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish an unredacted copy of such exhibit, or a copy of any omitted schedule or exhibit, to the SEC upon request.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SIGHT SCIENCES, INC. | ||
| Date: March 4, 2026 | By: | /s/ James Rodberg |
|---|---|---|
| James Rodberg | ||
| Chief Financial Officer (Principal Financial and Accounting Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name and Signature | Title | Date |
|---|---|---|
| /s/ Paul Badawi | President, Chief Executive Officer and Director | March 4, 2026 |
| Paul Badawi | (Principal Executive Officer) | |
| /s/ James Rodberg | Chief Financial Officer (Principal Financial | March 4, 2026 |
| James Rodberg | and Accounting Officer) | |
| /s/ Staffan Encrantz | Chairperson of the Board of Directors | March 4, 2026 |
| Staffan Encrantz | ||
| /s/ David Badawi | Chief Technology Officer and Director | March 4, 2026 |
| David Badawi, M.D. | ||
| /s/ Tamara Fountain | Director | March 4, 2026 |
| Tamara Fountain, M.D. | ||
| /s/ Gerhard Burbach | Director | March 4, 2026 |
| Gerhard Burbach | ||
| /s/ Catherine Mazzacco | Director | March 4, 2026 |
| Catherine Mazzacco | ||
| /s/ Donald Zurbay | Director | March 4, 2026 |
| Donald Zurbay | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.